Liquidity
1.95 was 1.17 in 2024
Short-term debts fell from €24,649 to €11,837.
ScopeMed
Lifetime
3 annual accounts with figures on one time axispeak €14,283 (2024)
€8,757▼ 38.7%
lowest -€8,827 (2023)
€7,191▼ 31.0%
peak €11,284 (2025)
€11,284▲ 176%
€11,837▼ 52.0%
Board1 name since 2023
1 director
Documentsfilings and deeds
27-08-202627 days late
2025micro format
Gross margin from €14,283 to €8,757Result from €10,419 to €7,191Equity from €4,093 to €11,284Debts from €24,649 to €11,837Cash from €4,616 to €16,135
Key points
from the 2025 annual accountsFilings
3 annual accounts 2 late
The 2025 accounts came latest: 27 days after the end of the period.
At the same address
308 companies
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as ScopeMed has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for ScopeMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0798843795
Amendment of the articles
Gazette deed
Incorporation
Founding capital of €2,500, 100 shares · Founder: · Appointment: (director) · published on 28-02-2023 · Gazette deed
First establishment
Groot-Bijgaardenstraat 14, Berchem-Sainte-Agathe
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ScopeMed Berchem-Sainte-Agathe | €23,121 | €8,757 | 48.8% | - |
| El Tigre Publishing Grimbergen | €33,573 | €13,543 | 38.5% | - |
| Editions Labrys Forest | €26,787 | €2,916 | 95.4% | - |
| AYO EDITIONS Brussels | €33,825 | €4,128 | 82.1% | - |
| R.S.V.P. Editions Schaerbeek | €41,305 | €3,013 | 4.8% | - |
| Leuvens Liedboek vzw Leuven | €12,702 | €4,471 | 13.4% | - |
| ASK Move Rixensart | €26,569 | €20,088 | 22.9% | - |
These companies have the same main activity as ScopeMed: book publishing (NACE 58110). They are comparable in size and age: total assets between €12,700 and €41,300, founded between 2021 and 2024.
Official details
Source: KBO- Status
- Active since 24-02-2023Normal situation
- Registered office
- 309 active companies are registered at this address53 started in the 12 months before. Source: KBO register, as of 13 November 2026.
- Activity
- Book publishingNACE 58110and 5 others
- Establishment unit
- 2.343.459.1271082 Berchem-Sainte-Agathe, since 24-02-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 17-12-2025
Insights on ScopeMed
ScopeMed files the micro format. That format states no turnover. The gross margin rose from -€6,808 in 2023 to €8,757 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ScopeMed
- What is the company number of ScopeMed?
- The company number of ScopeMed is 0798.843.795. The VAT number is the same number with BE in front: BE 0798.843.795.
- Where is ScopeMed based?
- The registered office is at Groot-Bijgaardenstraat 14, 1082 Berchem-Sainte-Agathe.Company details
- What does ScopeMed do?
- According to the KBO register, the main activity is book publishing (NACE 58110).
- What is the legal form of ScopeMed?
- ScopeMed is a private limited company (BV).
- When was ScopeMed founded?
- ScopeMed was founded on 24-02-2023.
- Is ScopeMed still active?
- Yes, ScopeMed is an active enterprise in the KBO register.
- What is the turnover of ScopeMed?
- The turnover in financial year 2025 is ≈ €67,000. This figure is estimated from the gross margin of €8,757 and 6,298 comparable companies of the same size. It probably lies between €30,000 and €160,000. It is a rough estimate.Financials
- Is ScopeMed profitable?
- In financial year 2025, ScopeMed made a profit of €7,191.
- Where can I find the annual accounts of ScopeMed?
- ScopeMed filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ScopeMed due?
- ScopeMed must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.